Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study

Aytug Kizilors(King's College Hospital NHS Foundation Trust), Hugues de Lavallade(King's College Hospital), Clare Wykes(Tunbridge Wells Hospital), Sophie Jackson(University of Cambridge), Simon Weston-Smith(East Sussex Healthcare NHS Trust), Elena Crisà(Candiolo Cancer Institute), Christopher Pocock(East Kent Hospitals University NHS Foundation Trust), Austin Kulasekararaj(King's College London), Syed A. Mian(The Francis Crick Institute), Maadh Aldouri(King's College Hospital NHS Foundation Trust), Patrick Harrington(King's College London), Emily Bart‐Smith(King's College Hospital NHS Foundation Trust), Richard Gale(York Hospital), Antonio Pagliuca, Franck E. Nicolini(Université Claude Bernard Lyon 1), Robin Ireland(King's College Hospital NHS Foundation Trust), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Steve Best(King's College London), Nicholas Lea(King's College Hospital NHS Foundation Trust), Tim Corbett(University Hospitals Sussex NHS Foundation Trust), Ghulam J. Mufti(King's College London), Kavita Raj(Johns Hopkins Hospital), Jamal Anwar(King's College Hospital NHS Foundation Trust), Donal P. McLornan(King's College London)
The Lancet Haematology
April 26, 2019
Cited by 56


Related Papers